We currently do not have sufficient information about the CEO.
Key information
John Payne
Chief executive officer
US$1.0m
Total compensation
CEO salary percentage
38.89%
CEO tenure
2yrs
CEO ownership
0.06%
Management average tenure
no data
Board average tenure
9.9yrs
Recent management updates
Recent updates
CEO Compensation Analysis
How has John Payne's remuneration changed compared to ZIVO Bioscience's earnings?
Date
Total Compensation
Salary
Company Earnings
Sep 30 2023
n/a
n/a
-US$9m
Jun 30 2023
n/a
n/a
-US$9m
Mar 31 2023
n/a
n/a
-US$9m
Dec 31 2022
US$1m
US$398k
-US$9m
Sep 30 2022
n/a
n/a
-US$9m
Jun 30 2022
n/a
n/a
-US$9m
Mar 31 2022
n/a
n/a
-US$9m
Dec 31 2021
US$689k
n/a
-US$9m
Sep 30 2021
n/a
n/a
-US$7m
Jun 30 2021
n/a
n/a
-US$9m
Mar 31 2021
n/a
n/a
-US$9m
Dec 31 2020
US$1m
n/a
-US$9m
Sep 30 2020
n/a
n/a
-US$11m
Jun 30 2020
n/a
n/a
-US$10m
Mar 31 2020
n/a
n/a
-US$11m
Dec 31 2019
US$49k
n/a
-US$12m
Sep 30 2019
n/a
n/a
-US$10m
Jun 30 2019
n/a
n/a
-US$13m
Mar 31 2019
n/a
n/a
-US$14m
Dec 31 2018
US$87k
n/a
-US$15m
Sep 30 2018
n/a
n/a
-US$15m
Jun 30 2018
n/a
n/a
-US$14m
Mar 31 2018
n/a
n/a
-US$12m
Dec 31 2017
US$43k
n/a
-US$10m
Compensation vs Market: John's total compensation ($USD1.02M) is above average for companies of similar size in the German market ($USD398.30K).
Compensation vs Earnings: John's compensation has increased whilst the company is unprofitable.
CEO
John Payne (75 yo)
2yrs
Tenure
US$1,022,753
Compensation
Mr. John B. Payne serves as President, Chief Executive Officer and Chairman of the Board at ZIVO Bioscience, Inc. since January 7, 2022. He is the Chairman, Chief Executive Officer and President of COMPASS...
Board Members
Name
Position
Tenure
Compensation
Ownership
John Payne
President
10.5yrs
US$1.02m
0.057% € 12.3k
Nola Masterson
Independent Director
9.3yrs
US$118.67k
0.032% € 6.9k
Christopher Maggiore
Independent Director
10.4yrs
US$116.11k
12.26% € 2.7m
Alison Cornell
Lead Independent Director
2.9yrs
US$426.75k
2.5% € 541.0k
9.9yrs
Average Tenure
67.5yo
Average Age
Experienced Board: 9R80's board of directors are considered experienced (9.9 years average tenure).
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2024/01/23 12:33
End of Day Share Price
2023/10/26 00:00
Earnings
2023/09/30
Annual Earnings
2022/12/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
ZIVO Bioscience, Inc. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.